Chemically modified tetracyclines induce apoptosis in cultured mast cells

International Immunopharmacology

Volumn 5, Issue 11, 2005, Pages 1611-1621

  Sandler, Charlotta ^a   Nurmi, Katariina ^a   Lindstedt, Ken A ^b   Sorsa, Timo ^a   Golub, Lorne M ^c   Kovanen, Petri T ^b   Eklund, Kari K ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b WIHURI RESEARCH INSTITUTE   (Finland)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

Apoptosis; Chemically modified tetracyclines; Mast cell

Indexed keywords

4 DEDIMETHYLAMINOSANCYCLINE; 4 DEDIMETHYLAMINOTETRACYCLINE; 6ALPHA DEOXY 5 HYDROXY 4 DEDIMETHYLAMINOTETRACYCLINE; 9 AMINO 6 NOR 6 DEOXY 4 DEDIMETHYLAMINOTETRACYCLINE; CAMPTOTHECIN; CASPASE 3; CASPASE 9; DOXYCYCLINE; GROWTH FACTOR; INTERLEUKIN 3; PROTEIN BCL 2; STEM CELL FACTOR; TETRACYCLINE; THYMIDINE; TRITIUM; TRYPAN BLUE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CELL VIABILITY; CHEMICAL MODIFICATION; CONTROLLED STUDY; DECISION MAKING; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MAST CELL; MOUSE; NICK END LABELING; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYSTEMIC DISEASE;

ANIMALS; APOPTOSIS; CASPASES; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; HUMANS; MAST CELLS; MICE; MICE, INBRED BALB C; TETRACYCLINES;

EID: 22544455044     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2005.04.013     Document Type: Article

References (31)

1. P.A. Nigrovic, and D.M. Lee Mast cells in inflammatory arthritis Arthritis Res Ther 7 2005 1 11
2. K.K. Eklund, and H. Joensuu Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases Ann Med 35 2003 362 367
3. D.E. Woolley, and L.C. Tetlow Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion Arthritis Res 2 2000 65 74
4. I. Gotis-Graham, and H.P. McNeil Mast cell responses in rheumatoid synovium. Association of the MCTC subset with matrix turnover and clinical progression Arthritis Rheum 40 1997 479 489
5. Y.A. Mekori, C.K. Oh, and D.D. Metcalfe IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3 J Immunol 151 1993 3775 3784
6. M. Tsai, T. Takeishi, H. Thompson, K.E. Langley, K.M. Zsebo, and D.D. Metcalfe Induction of mast cell proliferation, maturation and heparin synthesis by the rat c-kit ligand, stem cell factor Proc Natl Acad Sci U S A 88 1991 6382 6386
7. Juurikivi A, Sandler C, Lindstedt KA, Kovanen PT, Juutilainen T, Leskinen M, et al. Inhibition of c-Kit tyrosine kinase with imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia; a potential approach for treatment of arthritis. Ann Rheum Dis. in press.
8. L.M. Golub, N.S. Ramamurthy, T.F. McNamara, R.A. Greenwald, and B.R. Rifkin Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs Crit Rev Oral Biol Med 2 1991 297 321
9. R.E. Seftor, E.A. Seftor, L.J. De, D.E. Kleiner, J. Leferson, and W.G. Stetler-Stevenson Chemically modified tetracycines inhibit human melanoma cell invasion and metastasis Clin Exp Metastasis 16 1998 217 225
10. Q. Meng, J. Xu, I.D. Goldberg, E.M. Rosen, R.A. Greenwald, and S. Fan Influence on chemically modified tetracycline on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells Clin Exp Metastasis 18 2000 139 146
11. M. Tolomeo, S. Grimaudo, S. Milano, M. La Rosa, V. Ferlazzo, and G. Di Bella Effects of chemically modified tetracyclines (CMTs) in sensitive, multidrug resistant and apoptosis resistant leukaemia cell lines Br J Pharmacol 133 2001 306 314
12. B.L. Lokeshwar, M.G. Selzer, B.Q. Zhu, N.L. Block, and L.M. Golub Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model Int J Cancer 98 2002 297 309
13. P. D'Agostino, V. Ferlazzo, S. Milano, M. La Rosa, G. Di Bella, and R. Caruso Chemically modified tetracyclines induce cytotoxic effects against J774 tumour cell line by activating the apoptotic pathway Int Immunopharmacol 3 2003 63 73
14. S.G. Holmes, K. Still, D.J. Buttle, N.J. Bishop, and P.S. Grabowski Chemically modified tetracyclines act through multiple mechanisms directly on osteoclast precursors Bone 35 2004 471 478
15. M.R. Acharya, J. Venitz, W.D. Figg, and A. Sparreboom Chemically modified tetracyclines as inhibitors of matrix metalloproteinases Drug Resist Updat 7 2004 195 208
16. C. Sandler, E. Ekokoski, K.A. Lindstedt, P.J. Vainio, T. Sorsa, and P.T. Kovanen Chemically modified tetracycline (CMT)-3 inhibits histamine release and cytokine production in mast cells; possible involvement of protein kinase C Inflamm Res 54 2005 304 312
17. E.Y. Chang, Z. Szallasi, P. Acs, V. Raizada, P.C. Wolfe, and C. Fewtrell Functional effects of overexpression of protein kinase C-alpha, -beta, -delta, -epsilon, and -eta in the mast cell line RBL-2H3 J Immunol 159 1997 2624 2632
18. E. Chaikin, H.J. Ziltener, and E. Razin Protein kinase C plays an inhibitory role in interleukin 3- and interleukin 4-mediated mast cell proliferation J Biol Chem 265 1990 22109 22116
19. D. Baranes, and E. Razin Protein kinase C regulates proliferation of mast cells and the expression of the mRNAs of fos and jun proto-oncogenes during activation by IgE-Ag or calcium ionophore A23187 Blood 78 1991 2354 2364
20. J.H. Butterfield, D. Weiler, G. Dewald, and G.L. Gleich Establishment of an immature mast cell line from a patient with mast cell leukemia Leuk Res 12 1988 345 355
21. K.K. Eklund, K.F. Austen, D.S. Friend, N. Ghildyal, V. Schiller, and R.L. Stevens Mouse bone marrow-derived mast cells (mBMMC) obtained in vitro from mice that are mast cell-deficient in vivo express the same panel of granule proteases as mBMMC and serosal mast cells from their normal littermates J Exp Med 180 1994 67 73
22. Saito, H. Ebisava, N. Sakaguchi, T. Onda, Y. Likura, and M. Yanagida Characterization of cord-blood-derived human mast cells cultured in the presence of steel factor and interleukin-6 Int Arch Allergy Immunol 107 1995 63 65
23. M.M. Islam, C.D. Franco, D.W. Courtman, and M.P. Bendeck A nonantibiotic chemically modified tetracycline (CMT-3) inhibits intimal thickening Am J Pathol 163 2003 1557 1566
24. M.A. Rudek, W.D. Figg, V. Dyer, W. Dahut, M.L. Turner, and S.M. Steinberg Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer J Clin Oncol 19 2001 584 592
25. R.S. Fife, B.T. Rougraff, C. Proctor, and G.W. Sledge Jr. Inhibition of proliferation and induction of apoptosis by doxycycline in cultured human osteosarcoma cells J Lab Clin Med 130 1997 530 534
26. J.T. Bettany, N.M. Peet, R.G. Wolowacz, T.M. Skerry, and P.S. Grabowski Tetracyclines induce apoptosis in osteoclasts Bone 27 2000 75 80
27. E. Yang, and S.J. Korsmeyer Molecular thanatopsis: a discourse on the BCL2 family and cell death Blood 88 1996 386 401
28. C. Cohen-Saidon, H. Nechushtan, S. Kahlon, N. Livni, A. Nissim, and E. Razin A novel strategy using single-chain antibody to show the importance of Bcl-2 in mast cell survival Blood 102 2003 2506 2512
29. Y.A. Mekori, A.M. Gilfillan, C. Akin, K. Hartmann, and D.D. Metcalfe Human mast cell apoptosis is regulated through Bcl-2 and Bcl-XL J Clin Immunol 21 2001 171 174
30. Y. Nishizuka Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C Science 258 1992 607 614
31. A. Tasinato, D. Boscoboinik, G.M. Bartoli, P. Maroni, and A. Azzi d-Alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties Proc Natl Acad Sci U S A 92 1995 12190 12194